• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.31% Nasdaq Up 0.98%

    Pernix Therapeutics Holdings, Inc. (PTX)

    -NasdaqGM
    8.51 0.02(0.24%) Jan 29, 4:00PM EST
    Add to Portfolio
    Prev Close:8.49
    Open:8.49
    Bid:8.21 x 1000
    Ask:9.33 x 1100
    1y Target Est:14.00
    Beta:2.64
    Next Earnings Date:25-Feb-15PTX Earnings announcement
    Day's Range:8.13 - 8.64
    52wk Range:2.05 - 11.68
    Volume:475,062
    Avg Vol (3m):548,677
    Market Cap:325.86M
    P/E (ttm):N/A
    EPS (ttm):-0.90
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PTX

    Comparison

    Symbol% ChgMkt Cap
    PTXUp 0.24%325.86M
    JNJ286.57B
    PFE200.55B

    Key Statistics

    Forward P/E (1 yr):9.56
    P/S (ttm):3.54
    Ex-Dividend Date:21-Aug-01

    Analysts

    Annual EPS Est (Dec-14) :-0.30
    Quarterly EPS Est (Dec-14) :0.16
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-1.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback